2413 Stock Overview
Provides medical-related services primarily to physicians and other healthcare professionals through Internet.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 2413 from our risk checks.
M3, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,288.50 |
| 52 Week High | JP¥2,982.00 |
| 52 Week Low | JP¥1,126.50 |
| Beta | 0.81 |
| 11 Month Change | -18.37% |
| 3 Month Change | -18.50% |
| 1 Year Change | -54.69% |
| 33 Year Change | -81.79% |
| 5 Year Change | -43.93% |
| Change since IPO | 1,284.66% |
Recent News & Updates
Some M3, Inc. (TSE:2413) Shareholders Look For Exit As Shares Take 26% Pounding
Aug 10
Results: M3, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 30Estimating The Intrinsic Value Of M3, Inc. (TSE:2413)
Jul 25Recent updates
Some M3, Inc. (TSE:2413) Shareholders Look For Exit As Shares Take 26% Pounding
Aug 10Results: M3, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 30Estimating The Intrinsic Value Of M3, Inc. (TSE:2413)
Jul 25Is M3 (TSE:2413) Using Too Much Debt?
Jul 12Investor Optimism Abounds M3, Inc. (TSE:2413) But Growth Is Lacking
Jun 24M3 (TSE:2413) Will Be Hoping To Turn Its Returns On Capital Around
May 21M3's (TSE:2413) Dividend Will Be Increased To ¥21.00
Mar 07Is M3, Inc. (TSE:2413) Worth JP¥2.1k Based On Its Intrinsic Value?
Feb 28Shareholder Returns
| 2413 | JP Healthcare Services | JP Market | |
|---|---|---|---|
| 7D | 11.8% | 6.6% | 7.5% |
| 1Y | -54.7% | -44.3% | 17.4% |
Return vs Industry: 2413 underperformed the JP Healthcare Services industry which returned -44.3% over the past year.
Return vs Market: 2413 underperformed the JP Market which returned 17.4% over the past year.
Price Volatility
| 2413 volatility | |
|---|---|
| 2413 Average Weekly Movement | 5.8% |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 10.1% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 2413's share price has been volatile over the past 3 months.
Volatility Over Time: 2413's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 12,100 | Itaru Tanimura | corporate.m3.com |
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain.
M3, Inc. Fundamentals Summary
| 2413 fundamental statistics | |
|---|---|
| Market cap | JP¥874.92b |
| Earnings (TTM) | JP¥44.11b |
| Revenue (TTM) | JP¥245.70b |
19.8x
P/E Ratio3.6x
P/S RatioIs 2413 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2413 income statement (TTM) | |
|---|---|
| Revenue | JP¥245.70b |
| Cost of Revenue | JP¥102.56b |
| Gross Profit | JP¥143.13b |
| Other Expenses | JP¥99.03b |
| Earnings | JP¥44.11b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 64.95 |
| Gross Margin | 58.26% |
| Net Profit Margin | 17.95% |
| Debt/Equity Ratio | 6.8% |
How did 2413 perform over the long term?
See historical performance and comparison